SCHEMBL3909447

SCHEMBL3909447

O=c1[nH]n(-c2ccccc2)c2ccc([N+](=O)[O-])cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.59
KMT2A Q03164 8/20 0.59
POLB P06746 2/20 0.59
PLEC Q15149 1/20 0.59
ALDH1A1 P00352 4/20 0.51
MPI P34949 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
MAPT P10636 7/20 0.49
LMNA P02545 3/20 0.49
G6PD P11413 1/20 0.49
TLR9 Q9NR96 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
TSHR P16473 1/20 0.47
PARP1 P09874 1/20 0.47
PHOSPHO1 Q8TCT1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2547220 0.89 MEN1 (0.59) MEN1KMT2APOLBPLECALDH1A1
SCHEMBL3646520 0.77 CNR1 (0.50) MEN1KMT2AMAPTLMNARAB9A
SCHEMBL2551210 0.76 MEN1 (0.53) MEN1KMT2APOLBPLECALDH1A1
SCHEMBL31482838 0.76 MAPT (0.53) MEN1KMT2APOLBPLECMAPT
SCHEMBL3916212 0.76 PARP1 (0.46) MEN1KMT2APOLBPLECMAPT
SCHEMBL3648969 0.76 MAPT (0.53) MEN1KMT2APOLBPLECMAPT
SCHEMBL31482835 0.76 MAPT (0.53) MEN1KMT2APOLBPLECMAPT
SCHEMBL23622814 0.76 TSHR (0.53) MEN1KMT2APOLBPLECALDH1A1
SCHEMBL31037043 0.76 MEN1 (0.49) MEN1KMT2APOLBPLECALDH1A1
SCHEMBL28715228 0.76 MEN1 (0.49) MEN1KMT2APOLBPLECALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528158-B2 Indazolone derivatives useful as 11b-HSD1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2009-05-05 US disclosed
EP-1797042-B1 INDOZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-01-07 EP disclosed
US-20060069269-A1 Novel indazolone derivatives useful as 11b-HSD1 inhibitors F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069269-A1 Novel indazolone derivatives useful as 11b-HSD1 inhibitors HSD17B1, HSD11B1, HSD17B7 MEN1 1310/4885KMT2A 4023/4885POLB 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.